This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abnova
product type :
antibody
product name :
CYP26A1 monoclonal antibody, clone F27 P6 A1
catalog :
MAB1857
quantity :
200 ug
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
F27 P6 A1
The same clone is also sold as:
The same clone is also sold as:
- Santa Cruz Biotechnology: sc-53618 HRP, sc-53618, sc-53618 AC
- Invitrogen: MA1-12889
reactivity :
human
application :
western blot, ELISA, immunohistochemistry - paraffin section
product information
catalog id :
MAB1857
product name :
CYP26A1 monoclonal antibody, clone F27 P6 A1
product description :
Mouse monoclonal antibody raised against synthetic peptide of CYP26A1.
clone name :
F27 P6 A1
isotype :
IgG1
gene name :
CYP26A1
gene alias :
CP26 CYP26 P450RAI P450RAI1
gene description :
cytochrome P450, family 26, subfamily A, polypeptide 1
immunogen :
A synthetic peptide corresponding to C-terminus of human CYP26A1.
form :
Liquid
recommend dilutions :
Western Blot (1-2 ug/mL). Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1-5 ug/mL). The optimal working dilution should be determined by the end user.
storage buffer :
In PBS (0.08% sodium azide)
storage instruction :
Store at -20 C. Aliquot to avoid repeated freezing and thawing.
quality control testing :
Antibody Reactive Against Synthetic Peptide.
note :
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
type clonality :
Antibody
raised in host species :
Mouse
antigen species target species :
Human
species reactivity cross reactivity :
Human
application key :
ELISA,IHC-P,WB-Re
size :
200 ug
autodate :
2009-06-01
updatetime :
2011-02-11 13:41:03
company information
Abnova
9th Fl., No.108, Jhouzih St.
Neihu District. Taipei City
114 Taiwan
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com877-853-6098
questions and comments